Legend Biotech (LEGN) Change in Acquisitions & Divestments (2020 - 2025)

Legend Biotech has reported Change in Acquisitions & Divestments for 6 years, with the latest figure at $381.1 million in Q3 2025.

• For the quarter ending Q3 2025, Change in Acquisitions & Divestments rose 111.09% year-over-year to $381.1 million; the trailing twelve-month figure through Sep 2025 stood at $1.2 billion (up 1286.33% YoY), and the FY2022 full-year result was $483.6 million, up 168.68% from the prior year.
• Change in Acquisitions & Divestments for Q3 2025 stood at $381.1 million, down from $3.9 billion in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $3.9 billion in Q2 2025, with the low at -$3.4 billion in Q3 2024.
• Historically, Change in Acquisitions & Divestments has averaged $365.5 million across 5 years, with a median of $190.6 million in 2022.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments surged 1125.82% — and 2024, when it plunged 247.0%.
• Legend Biotech's Change in Acquisitions & Divestments stood at $180.0 million in 2021, then surged by 168.68% to $483.6 million in 2022, then jumped by 383.23% to $2.3 billion in 2023, then sank by 247.0% to -$3.4 billion in 2024, then jumped by 111.09% to $381.1 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $381.1 million (Q3 2025), $3.9 billion (Q2 2025), and $374.0 million (Q1 2025), per Business Quant data.